Dosing of Erythropoiesis-Stimulating Agents Can Be Reduced by a New Administration Regimen

Background/Aims: At our hemodialysis (HD) unit, we noted a drop in the treatment dose of erythropoietin-stimulating agents (ESAs) when the frequency of dose adjustment was reduced fr